ПРОБІОТИКИ: ДВІ СТОРОНИ ОДНІЄЇ МЕДАЛІ

Автор(и)

  • D. V. Rotar Вищий державний навчальний заклад України «Буковинський державний медичний університет», м. Чернівці, Україна

DOI:

https://doi.org/10.24061/1727-4338.XIII.3.49.2014.44

Ключові слова:

пробіотики, переваги та недоліки пробіотичних препаратів, антибіотикорезистентність

Анотація

Резюме. В огляді висвітлені основні переваги та недоліки використання пробіотиків. Основна увага акцентована на негативних наслідках використання пробіотиків, у тому числі на формуванні  антибіотикорезистентності у пробіотичних штамів. Вказано на необхідність моніторингу на державному рівні формування стійкості пробіотичних штамів до антибіотиків.

Посилання

Khizhnyak OS, Krasnopol'skiy YuM. Biotekhnologicheskie aspekty sozdaniya preparatov na osnove probiotikov [Biotechnological aspects of creating products based on probiotics]. Visnyk Natsional'noho tekhnichnoho universytetu «KhPI». 2012;44:72-8. (in Russian).

Kligler B, Cohrssen A. Aliment Pharmacol Theren Probiotics. Am Fam Physician. 2008;78:1073-78. (in Ukrainian).

Rambaud JC, Buts JP, Corthier G, Flourie B. Gut Microflora Digestive physiology and Pathology. Paris: John Libbey Eurotext; 2006. 264 p.

Bondarenko VM. Molekulyarno-kletochnye mekhanizmy terapevticheskogo deystviya probioticheskikh preparatov [Molecular and cellular mechanisms of therapeutic action of probiotic preparations]. Farmateka. 2010;2:26-32. (in Russian).

Floch MH, Walker WA, Guandalini S, Hibberd P, Gorbach S, Surawicz C, et al. Floch M. H. Recommendations for probiotic use-2008. J Clin astroenterol. 2008 Jul;42 Suppl 2:S104-8. doi: 10.1097/MCG.0b013e31816b903f.

Dekhtiarenko NV, Shynkarenko LM, Duhan OM. Kryterii vidboru probiotychnykh shtamiv mikroorhanizmiv [Criteria for selection of probiotic strains of microorganisms]. Naukovi zapysky. Seriia Biolohiia ta ekolohiia. 2007;67:30-6. (in Ukrainian).

Okhotnikova EN. Mikrobiotsenoz kishechnika: Osnovnye ponyatiya, narusheniya i ikh korrektsiya [Intestinal microbiocenosis: Basic concepts, disorders and their correction]. Mystetstvo likuvannia. 2010;4:34-40. (in Russian).

Sheu BS, Cheng HC, Kao AW, Wang ST, Yang YJ, Yang HB, et al. Pretreatment with Lactobacillus- and Bifidobacterium-containing yogurt can improve the efficacy of quadruple therapy in eradicating residual Helicobacter pylori infection after failed triple therapy. Am J Clin Nutr. 2006 Apr;83(4):864-9. doi: 10.1093/ajcn/83.4.864.

Lam EK, Yu L, Wong HP, Wu WK, Shin VY, Tai EK, et al. Probiotic Lactobacillus rhamnosus GG enhances gastric ulcer healing in rats. Eur J Pharmacol. 2007 Jun 22;565(1-3):171-9. doi: 10.1016/j.ejphar.2007.02.050.

Zwolińska-Wcisło M, Brzozowski T, Mach T, Budak A, Trojanowska D, Konturek PC, et al. Are probiotics effective in the treatment of fungal colonization of the gastrointestinal tract? Experimental and clinical studies. J Physiol Pharmacol. 2006 Nov;57 Suppl 9:35-49.

Neschislyaev VA, Pshenichnov RA, Archakova EG, Chistokhina LP, Fadeeva IV, izobretatel'; Permskoe nauchno-proizvodstvennoe ob"edinenie "Biomed", patentoobladatel'. Sposob opredeleniya antagonisticheskoy aktivnosti probiotikov [The method for determining the antagonistic activity of probiotics]. Patent Rossii № 2187801. 2002 Avg 20. (in Russian).

Geuking MB, Cahenzli J, Lawson MA, Ng DC, Slack E, Hapfelmeier S, et al. Intestinal bacterial colonization induces mutualistic regulatory T-cell responses. Immunity. 2011 May 27;34(5):794-806. doi: 10.1016/j.immuni.2011.03.021.

Khristich TN. Mikrobiotsenoz kishechnika: mekhanizmy razvitiya, klinika disbioza i vozmozhnaya korrektsiya ego narusheniy [Intestinal microbiocenosis: mechanisms of development, clinical dysbiosis and possible correction of its disorders]. Suchasna hastroenterolohiia. 2010;1:86-91. (in Russian).

Onishchenko GG. MUK 4.2.2602-10. 4.2. Metody kontrolya. Biologicheskie i mikrobiologicheskie faktory. Sistema predregistratsionnogo doklinicheskogo izucheniya bezopasnosti preparatov. Otbor, proverka i khranenie proizvodstvennykh shtammov, ispol'zuemykh pri proizvodstve probiotikov [Control methods. Biological and microbiological factors. The system of pre-registration preclinical study of drug safety. Selection, verification and storage of production strains used in the production of probiotics]: metod. ukazaniya. Moskva: FGUN GISK im. Tarasevicha LA; 2010. 78 p. (in Russian).

Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA, et al. The toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science. 2011 May 20;332(6032):974-7. doi: 10.1126/science.1206095

Hordiienko PA, Chuieshov VI, Pashnieva RO. Rozrobka skladu ta tekhnolohii tabletok-iader kombinovanoho probiotyka [Development of the composition and technology of the tablet-core of the combined probiotic]. Farmakom. 2009;3:19-23. (in Ukrainian).

Baranovskiy AYu, Baranovskiy EA. Disbakterioz kishechnika [Intestinal dysbiosis]. Sankt-Peterburg: Piter; 2008. 240 p. (in Russian).

de Bortoli N, Leonardi G, Ciancia E, Merlo A, Bellini M, Costa F, et al. Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics. Am J Gastroenterol. 2007 May;102(5):951-6. doi: 10.1111/j.1572-0241.2007.01085.x.

Mc Farland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol. 2006 Apr;101(4):812-22. doi: 10.1111/j.1572-0241.2006.00465.x.

Young VВ. The intestinal microbiota in health and disease. Curr Opin Gastroenterol. 2012 Jan;28(1):63-9. doi: 10.1097/MOG.0b013e32834d61e9.

Khavkin AI, Zhikhareva NS. Terapiya antibiotik-assotsiirovannogo disbakterioza [Therapy of antibiotic-associated dysbiosis]. Russkiy meditsinskiy zhurnal. 2006;19(14):1386.(inRussian).

Szajewska H, Ruszczyński M, Radzikowski A. Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials. J Pediatr. 2006 Sep;149(3):367-372. doi: 10.1016/j.jpeds.2006.04.053.

Koning CJ, Jonkers DM, Stobberingh EE, Mulder L, Rombouts FM, Stockbrügger RW. The effect of a multispecies probiotic on the intestinal microbiota and bowel movements in healthy volunteers taking antibiotic amoxicillin. Am J Gastroenterol. 2008 Jan;103(1):178-89. doi: 10.1111/j.1572-0241.2007.01547.x.

Borivant M, Strober W. The mechanism of action of probiotics. Curr Opin Gastroenterol. 2007 Nov;23(6):679-92. doi: 10.1097/MOG.0b013e3282f0cffc.

Ob utverzhdenii otraslevogo standarta «Protokol vedeniya bol'nykh. Disbakterioz kishechnika» [On approval of the industry standard “Protocol for the management of patients. Intestinal Dysbiosis"]. Prikaz MZ RF № 231 ot 09.06.2003 [Internet]. Moskva; 2003 [tsitirovano 2014 Yanv 28]. Dostupno: http://docs.cntd.ru/document/1200119089. (in Russian).

Kukkonen K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, et al. Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial. Pediatrics. 2008 Jul;122(1):8-12. doi: 10.1542/peds.2007-1192.

Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, et al. Enterotypes of the human gut microbiome. Nature. 2011 May 12;473(7346):174-80. doi: 10.1038/nature09944.

Filimonova NI, Dyka OM, Velykodanov HL, Mukhamed ME. Osnovni vlastyvosti probiotykiv ta zhovchorezystentnist' [Basic properties of probiotics and bile resisting]. Klinichna farmatsiia. 2011;2(15):38-40. (in Ukrainian).

Baranovskiy AYu, Kondrashina EA. Disbakterioz kishechnika [Intestinal dysbiosis]. Izd. 3-e. Sankt-Peterburg: Piter; 2007. 240 p. (in Russian).

DSTU 7357:2013 Moloko ta molochni produkty. Metody mikrobiolohichnoho kontroliuvannia [Milk and dairy products]. Kyiv: Minekonomrozvytku Ukrainy; 2014. 38 p. (in Ukrainian).

Courvalin Р. Antibiotikorezistentnost' probiotikov: dovody «za» i «protiv» [Antibiotic resistance of probiotics: the pros and cons]. Zdorov'ia Ukrainy. 2008;17:68-70. (in Russian).

##submission.downloads##

Опубліковано

2018-12-20

Номер

Розділ

Статті